Cargando…

Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling

BACKGROUND: Many receptors function by binding to multiple ligands, each eliciting a distinct biological output. The extracellular domain of the human prolactin receptor (hPRL-R) uses an identical epitope to bind to both prolactin (hPRL) and growth hormone (hGH), yet little is known about how each h...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizk, Shahir S, Kouadio, Jean-Louis K, Szymborska, Anna, Duguid, Erica M, Mukherjee, Somnath, Zheng, Jiamao, Clevenger, Charles V, Kossiakoff, Anthony A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300558/
https://www.ncbi.nlm.nih.gov/pubmed/25589173
http://dx.doi.org/10.1186/s12964-014-0080-8
_version_ 1782353538547974144
author Rizk, Shahir S
Kouadio, Jean-Louis K
Szymborska, Anna
Duguid, Erica M
Mukherjee, Somnath
Zheng, Jiamao
Clevenger, Charles V
Kossiakoff, Anthony A
author_facet Rizk, Shahir S
Kouadio, Jean-Louis K
Szymborska, Anna
Duguid, Erica M
Mukherjee, Somnath
Zheng, Jiamao
Clevenger, Charles V
Kossiakoff, Anthony A
author_sort Rizk, Shahir S
collection PubMed
description BACKGROUND: Many receptors function by binding to multiple ligands, each eliciting a distinct biological output. The extracellular domain of the human prolactin receptor (hPRL-R) uses an identical epitope to bind to both prolactin (hPRL) and growth hormone (hGH), yet little is known about how each hormone binding event triggers the appropriate response. FINDINGS: Here, we utilized a phage display library to generate synthetic antibodies (sABs) that preferentially modulate hPRL-R function in a hormone-dependent fashion. We determined the crystal structure of a sAB-hPRL-R complex, which revealed a novel allosteric mechanism of antagonism, whereby the sAB traps the receptor in a conformation more suitable for hGH binding than hPRL. This was validated by examining the effect of the sABs on hormone internalization via the hPRL-R and its downstream signaling pathway. CONCLUSIONS: The findings suggest that subtle structural changes in the extracellular domain of hPRL-R induced by each hormone determine the biological output triggered by hormone binding. We conclude that sABs generated by phage display selection can detect these subtle structural differences, and therefore can be used to dissect the structural basis of receptor-ligand specificity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-014-0080-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4300558
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43005582015-01-22 Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling Rizk, Shahir S Kouadio, Jean-Louis K Szymborska, Anna Duguid, Erica M Mukherjee, Somnath Zheng, Jiamao Clevenger, Charles V Kossiakoff, Anthony A Cell Commun Signal Short Report BACKGROUND: Many receptors function by binding to multiple ligands, each eliciting a distinct biological output. The extracellular domain of the human prolactin receptor (hPRL-R) uses an identical epitope to bind to both prolactin (hPRL) and growth hormone (hGH), yet little is known about how each hormone binding event triggers the appropriate response. FINDINGS: Here, we utilized a phage display library to generate synthetic antibodies (sABs) that preferentially modulate hPRL-R function in a hormone-dependent fashion. We determined the crystal structure of a sAB-hPRL-R complex, which revealed a novel allosteric mechanism of antagonism, whereby the sAB traps the receptor in a conformation more suitable for hGH binding than hPRL. This was validated by examining the effect of the sABs on hormone internalization via the hPRL-R and its downstream signaling pathway. CONCLUSIONS: The findings suggest that subtle structural changes in the extracellular domain of hPRL-R induced by each hormone determine the biological output triggered by hormone binding. We conclude that sABs generated by phage display selection can detect these subtle structural differences, and therefore can be used to dissect the structural basis of receptor-ligand specificity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-014-0080-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-15 /pmc/articles/PMC4300558/ /pubmed/25589173 http://dx.doi.org/10.1186/s12964-014-0080-8 Text en © Rizk et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Rizk, Shahir S
Kouadio, Jean-Louis K
Szymborska, Anna
Duguid, Erica M
Mukherjee, Somnath
Zheng, Jiamao
Clevenger, Charles V
Kossiakoff, Anthony A
Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
title Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
title_full Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
title_fullStr Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
title_full_unstemmed Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
title_short Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
title_sort engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300558/
https://www.ncbi.nlm.nih.gov/pubmed/25589173
http://dx.doi.org/10.1186/s12964-014-0080-8
work_keys_str_mv AT rizkshahirs engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling
AT kouadiojeanlouisk engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling
AT szymborskaanna engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling
AT duguidericam engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling
AT mukherjeesomnath engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling
AT zhengjiamao engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling
AT clevengercharlesv engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling
AT kossiakoffanthonya engineeringsyntheticantibodybindersforallostericinhibitionofprolactinreceptorsignaling